Pfizer and BioNTech Collaborate to Develop mRNA-Based Influenza Vaccines

10:17 EDT 16 Aug 2018 | R&D Magazine

Under the terms of the agreement, BioNTech and Pfizer will jointly conduct research and development activities to help advance mRNA-based flu vaccines.
Contributed Author: 
BioNTech AG
Topics: 
Drug Discovery

Original Article: Pfizer and BioNTech Collaborate to Develop mRNA-Based Influenza Vaccines

More From BioPortfolio on "Pfizer and BioNTech Collaborate to Develop mRNA-Based Influenza Vaccines"